Skip to main content

Advertisement

Log in

Bypassing T cell 'exhaustion'

  • News & Views
  • Published:

From Nature Immunology

View current issue Submit your manuscript

The hypoxia-inducible factor (HIF) pathway controls diverse aspects of the immunological response. Enhanced HIF activity is able to extend and potentiate the effector response of CD8+ T cells against chronic infections and tumor growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Enhanced HIF signaling drives an activated effector fate of CD8+ T cells and counteracts exhaustion in response to chronic exposure to antigen.

Katie Vicari

References

  1. Wherry, E.J. Nat. Immunol. 12, 492–499 (2011).

    Article  CAS  PubMed  Google Scholar 

  2. Kao, C. et al. Nat. Immunol. 12, 663–671 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Shin, H. et al. Immunity 31, 309–320 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Doedens, A.L. et al. Nat. Immunol. 14, 1173–1182 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Dang, E.V. et al. Cell 146, 772–784 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Shi, L.Z. et al. J. Exp. Med. 208, 1367–1376 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Li, M. & Kim, W.Y. J. Cell. Mol. Med. 15, 187–195 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wherry, E.J. et al. Immunity 27, 670–684 (2007).

    CAS  PubMed  Google Scholar 

  9. Kaech, S.M. & Cui, W. Nat. Rev. Immunol. 12, 749–761 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Paley, M.A. et al. Science 338, 1220–1225 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Zhou, X. et al. Immunity 33, 229–240 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Baitsch, L. et al. J. Clin. Invest. 121, 2350–2360 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zhou, Q. et al. Blood 117, 4501–4510 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Göthert, J.R. et al. Cancer Immunol. Immunother. (2013).

  15. McNamee, E.N., Korns, J.D., Homann, D. & Clambey, E.T. Immunol. Res. 55, 58–70 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joachim R Göthert.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Göthert, J. Bypassing T cell 'exhaustion'. Nat Immunol 14, 1114–1116 (2013). https://doi.org/10.1038/ni.2742

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.2742

  • Springer Nature America, Inc.

Navigation